Past hepatitis B virus infection in rheumatoid arthritis patients receiving biological and/or nonbiological disease-modifying antirheumatic drugs

To evaluate the prevalence of past infection with hepatitis B virus (HBV) in patients with rheumatoid arthritis (RA) and the incidence of its reactivation under treatment with biological and/or nonbiological disease-modifying antirheumatic drugs (DMARDs), 239 patients receiving DMARD therapy were co...

Descripción completa

Detalles Bibliográficos
Autor principal: Mori, Shunsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236827/
https://www.ncbi.nlm.nih.gov/pubmed/21528424
http://dx.doi.org/10.1007/s10165-011-0458-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236827/
https://www.ncbi.nlm.nih.gov/pubmed/21528424
http://dx.doi.org/10.1007/s10165-011-0458-z

Ejemplares similares